🔗 Permalink

Inventor profile of:

Min Shen

City:

Boyds, Maryland

Country:

United States

Published Applications:

Last publication date:

2019-08-08

Top Assignees for applications by Min Shen

The entities that hold a legal rights for patent applications filed by inventor Shen Min:

The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
Icahn School of Medicine at Mount Sinai 3 New York, NY United States
THE ROCKEFELLER UNIVERSITY 3 New York, NY United States
University of Utah Research Foundation 2 Salt Lake City, UT United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
The University of North Carolina at Chapel Hill 2 Chapel Hill, NC United States
The United States of American, as Represented by the Decretary, Department of Health and Human 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services. 1 Silver Spring, MD United States
The United States of America as represented by the Secretary, Department of Health and Human Services, National Institutes of Health 1 Washington, DC United States
Dept. of Health and Human Services, National Institutes of Health 1 Bethesda, MD United States
DUKE UNIVERSITY 1 Durham, NC United States
Dana-Farber-Cancer Institute, Inc. 1 Boston, MA United States
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 1 Cambridge, MA United States
The United States of America,as represented by the Secretary, Department of Health and Human Service 1 Bethesda, MD United States
The USA, as represented by the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
Afraxis Holdings, Inc. 1 La Jolla, CA United States

Recent patent applications by Shen Min

Min Shen from Boyds, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-08

US20190241551A1

Chemistry; metallurgy

Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer

#2 | 2019-03-07

US20190071434A1

Chemistry; metallurgy

Mutant IDH1 inhibitors useful for treating cancer

#3 | 2019-02-21

US20190054047A1

Human necessities

TREATMENT OF MALIGNANT ADRENOCORTICAL TUMOR WITH NICLOSAMIDE AND OTHER COMPOUNDS

#4 | 2019-01-31

US20190030031A1

Human necessities

Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

#5 | 2018-09-27

US20180271929A1

Human necessities

Compositions and methods for identifying and treating dystonia disorders

#6 | 2018-04-19

US20180105508A1

Chemistry; metallurgy

Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof

#7 | 2017-11-23

US20170334918A1

Chemistry; metallurgy

BMP inhibitors and methods of use thereof

#8 | 2017-02-09

US20170035760A1

Human necessities

GALACTOKINASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF ASSOCIATED DISEASES AND DISORDERS

#9 | 2016-02-18

US20160046633A1

Chemistry; metallurgy

BMP inhibitors and methods of use thereof

#10 | 2015-12-31

US20150374697A1

Human necessities

Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

#11 | 2015-07-02

US20150183744A1

Chemistry; metallurgy

Activators of human pyruvate kinase

#12 | 2015-02-19

US20150050325A1

Chemistry; metallurgy

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

#13 | 2015-01-29

US20150031693A1

Chemistry; metallurgy

PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME

#14 | 2014-09-25

US20140288100A1

Chemistry; metallurgy

Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

#15 | 2013-09-26

US20130251761A1

Human necessities

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

#16 | 2013-05-02

US20130109672A1

Chemistry; metallurgy

ACTIVATORS OF HUMAN PYRUVATE KINASE

InventorID:

224207 ⎘